Lupin Limited has informed the Exchange regarding a press release dated October 06, 2021, titled "Lupin Receives Tentative Approval from U.S. FDA for Brexpiprazole Tablets.".
Lupin Limited has informed the Exchange regarding a press release dated October 06, 2021, titled "Lupin Receives Tentative Approval from U.S. FDA for Brexpiprazole Tablets.".